Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (221-230 of 327) with videos related to

Pageof 33
Sort By:
Ebiomedicine|September 27, 2021
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccinationBrent Appelman, Karlijn van der Straten, A H Ayesha Lavell, et al.
NPJ Vaccines|April 22, 2022
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimersAlessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, et al.
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
NPJ Vaccines|July 14, 2023
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigensGregory M Martin, Rebecca A Russell, Philip Mundsperger, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Cell Host & Microbe|April 24, 2021
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infectionHejun Liu, Meng Yuan, Deli Huang, et al.
NPJ Vaccines|September 30, 2023
Assessing immunogenicity barriers of the HIV-1 envelope trimerLiridona Maliqi, Nikolas Friedrich, Matthias Glögl, et al.
Journal of Virology|January 16, 2015
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env genePavel Pugach, Gabriel Ozorowski, Albert Cupo, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
Pageof 33

Showing results (221-230 of 327) with videos related to

Sort By:
Pageof 33
Ebiomedicine|September 27, 2021
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccinationBrent Appelman, Karlijn van der Straten, A H Ayesha Lavell, et al.
NPJ Vaccines|April 22, 2022
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimersAlessandra Gallinaro, Maria Franca Pirillo, Yoann Aldon, et al.
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
NPJ Vaccines|July 14, 2023
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigensGregory M Martin, Rebecca A Russell, Philip Mundsperger, et al.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Cell Host & Microbe|April 24, 2021
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infectionHejun Liu, Meng Yuan, Deli Huang, et al.
NPJ Vaccines|September 30, 2023
Assessing immunogenicity barriers of the HIV-1 envelope trimerLiridona Maliqi, Nikolas Friedrich, Matthias Glögl, et al.
Journal of Virology|January 16, 2015
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env genePavel Pugach, Gabriel Ozorowski, Albert Cupo, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Ebiomedicine|January 3, 2025
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadthKatrina M Pollock, Hannah M Cheeseman, Leon R McFarlane, et al.
Pageof 33